feed,title,long_url,short_url
Investing,Bitcoin: All-Time Highs Within Reach but $120K Resistance Remains Key Hurdle,https://www.investing.com/analysis/cardano-and-solana-rally-while-bitcoin-holds-steady--monday-crypto-update-200664067,
Investing,Market Pushed to the Max as Volatility Measures Hit a Wall Ahead of Key Earnings,https://www.investing.com/analysis/market-pushed-to-the-max-as-volatility-measures-hit-a-wall-ahead-of-earnings-200664065,
Investing,Diaceutics maintains FY targets with 22% revenue growth in H1,https://www.investing.com/news/stock-market-news/diaceutics-maintains-fy-targets-with-22-revenue-growth-in-h1-93CH-4145089,
Investing,Japan stocks lower at close of trade; Nikkei 225 down 0.19%,https://www.investing.com/news/stock-market-news/japan-stocks-lower-at-close-of-trade-nikkei-225-down-019-4145085,
Investing,Bossard reports mixed 2Q results amid muted industrial markets,https://www.investing.com/news/stock-market-news/bossard-reports-mixed-2q-results-amid-muted-industrial-markets-93CH-4145084,
Investing,European stocks slip lower on trade uncertainties; earnings season continues,https://www.investing.com/news/stock-market-news/european-stocks-slip-lower-on-trade-uncertainties-earnings-season-continues-4145068,
Investing,Sanofi to acquire U.K. vaccine developer Vicebio for up to $1.6 billion,https://www.investing.com/news/stock-market-news/sanofi-to-acquire-uk-vaccine-developer-vicebio-for-up-to-16-billion-4145081,
